Could a blood filter save stroke patients?

NCT ID NCT07127484

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a procedure called hemoadsorption, which filters the blood, can help people with severe ischemic stroke. Researchers will compare standard care plus hemoadsorption to standard care alone in 116 adults. The goal is to see if the procedure reduces the chance of severe disability or death.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

hemoadsorption (a blood-filtering procedure)

What this could lead to

If it works, this could offer a new way to reduce disability after severe stroke by filtering harmful substances from the blood.

What could go wrong

This is an early-stage trial with only 116 participants, so results may not apply to all stroke patients. The procedure also carries risks like bleeding or infection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital)

    RECRUITING

    Wuhu, Anhui, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact